搜索
Heartflow Inc
HTFL添加自选
29.690USD
+0.350+1.19%
交易中 （美东）报价延迟15分钟
2.53B总市值
亏损市盈率 TTM
关键数据
29.350今开
30.560最高
996.80K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
1.17%换手率
29.340昨收
28.890最低
21.09M成交额
亏损市盈率静
8.42市净率
0.00%股息率 TTM
-42.32%ROA
41.22352周最高
0.34量比
-96.43M净利润
85.28M总股本
-3.0875每股收益TTM
--Beta
--ROE
20.13052周最低
5.69%振幅
80.18%毛利率
2.53B总市值
-1.19回报/风险
4.48%风险率
TradingKey Heartflow Inc股票评分
单位: USD 更新时间: 2026-06-30操作建议
Heartflow Inc当前公司基本面数据相对健康，增长潜力很大。当前估值合理，在医疗设备与耗材行业排名116/204位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价37.40。中期看，股价处于上升通道。近一个月，市场表现一般，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Heartflow Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Heartflow Inc亮点
亮点风险
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
业绩高增长
公司营业收入稳步增长，连续3年增长101.93%
估值低估
公司最新PE估值-9.50，处于3年历史低位
分析师目标
根据
7
位分析师
买入
评级
37.400
目标均价
+7.32%
涨幅空间
Heartflow Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Heartflow Inc简介
HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
公司代码HTFL
公司Heartflow Inc
CEOFarquhar (John C. M)
网址https://www.heartflow.com/
相关品种
+2.45%
+2.37%
+1.60%
+1.25%
+1.51%
+0.71%
-1.30%
+1.24%
+0.69%
+6.00%
-0.42%
+0.56%
+1.39%
+1.51%
+2.77%
+1.33%
+0.92%
+2.42%
+0.96%
+5.95%热门品种
常见问题
Heartflow Inc(HTFL)的当前股价是多少？
Heartflow Inc(HTFL)的当前股价是 29.34。
Heartflow Inc的股票代码是什么？
Heartflow Inc的股票代码是HTFL。
Heartflow Inc股票的52周最高点是多少？
Heartflow Inc股票的52周最高点是41.22。
Heartflow Inc股票的52周最低点是多少？
Heartflow Inc股票的52周最低点是20.13。
Heartflow Inc的市值是多少？
Heartflow Inc的市值是3.01B。
现在Heartflow Inc(HTFL)的股票是买入、持有还是卖出？
根据分析师评级，Heartflow Inc(HTFL)的总体评级为买入，目标价格为37.40。
Heartflow Inc(HTFL)股票的每股收益（EPS TTM）是多少
Heartflow Inc(HTFL)股票的每股收益（EPS TTM）是-3.17。